Read more about the article Clinical Research Update – Lambda Newsletter – June 2024
Clinical Research Updates - June 2024 Newsletter

Clinical Research Update – Lambda Newsletter – June 2024

Regulations, Notices & Guidance June 10, 2024: The FDA announced the "Emerging Drug Safety Technology Meetings; Program Announcement." The Center for Drug Evaluation and Research (CDER) introduced the Emerging Drug…

Continue ReadingClinical Research Update – Lambda Newsletter – June 2024
Read more about the article Overcoming Challenges in a Multicenter Psychiatric Clinical Trial: Bioequivalence Assessment of Paliperidone Palmitate Extended-Release Injectable Suspension, 546 mg
Overcoming Challenges in a Multicenter Psychiatric Clinical Trial: Bioequivalence Assessment of Paliperidone Palmitate Extended-Release Injectable Suspension, 546 mg

Overcoming Challenges in a Multicenter Psychiatric Clinical Trial: Bioequivalence Assessment of Paliperidone Palmitate Extended-Release Injectable Suspension, 546 mg

Blog

Continue ReadingOvercoming Challenges in a Multicenter Psychiatric Clinical Trial: Bioequivalence Assessment of Paliperidone Palmitate Extended-Release Injectable Suspension, 546 mg
Read more about the article Singlicate well assay for the analysis of Enoxaparin Pharmacodynamic Biomarkers (Anti-Factor Xa, Anti-Factor IIa, and TFPI) for the Bioequivalence study.
Singlicate well assay for the analysis of Enoxaparin Pharmacodynamic Biomarkers (Anti-Factor Xa, Anti-Factor IIa, and TFPI) for the Bioequivalence study. - Poster presented at 18th WRIB

Singlicate well assay for the analysis of Enoxaparin Pharmacodynamic Biomarkers (Anti-Factor Xa, Anti-Factor IIa, and TFPI) for the Bioequivalence study.

BLOG

Continue ReadingSinglicate well assay for the analysis of Enoxaparin Pharmacodynamic Biomarkers (Anti-Factor Xa, Anti-Factor IIa, and TFPI) for the Bioequivalence study.
Read more about the article Exploring the Evolving Landscape of Ophthalmology Clinical Development
Leading CRO for Ophthalmology clinical development - clinical trials

Exploring the Evolving Landscape of Ophthalmology Clinical Development

Few fields in clinical research are as dynamic and promising as ophthalmology. With the global population ageing and eye diseases becoming more prevalent, there is a growing demand for innovative treatments and therapies. This blog explores the emerging trends and updates that are shaping the ophthalmology clinical development landscape.

Continue ReadingExploring the Evolving Landscape of Ophthalmology Clinical Development
Read more about the article Ensuring Data Integrity: FDA’s Draft Guidance on In Vivo Bioavailability and Bioequivalence Studies
Ensuring Data Integrity: FDA's Draft Guidance on In Vivo Bioavailability and Bioequivalence Studies

Ensuring Data Integrity: FDA’s Draft Guidance on In Vivo Bioavailability and Bioequivalence Studies

The FDA recently unveiled the draft guidance for the industry titled, “Data Integrity for In Vivo Bioavailability and Bioequivalence Studies.” This draft guidance serves as a framework for maintaining the highest standards of data integrity in clinical and bioanalytical domains, crucial for supporting investigational new drug applications, new drug applications, and abbreviated new drug applications.

Continue ReadingEnsuring Data Integrity: FDA’s Draft Guidance on In Vivo Bioavailability and Bioequivalence Studies